Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Lancet. Infectious Diseases|May 30, 2021
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trialBoris Revollo, Ignacio Blanco, Pablo Soler, et al.
Frontiers in Pediatrics|February 6, 2023
Feasibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen self-testing in school and summer camp attendeesAndreu Colom-Cadena, Héctor Martínez-Riveros, Anna Bordas, et al.
Scientific Reports|September 10, 2021
Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective studyEdy Nacarapa, M Elisa Verdu, Joana Nacarapa, et al.
International Journal of Environmental Research and Public Health|July 20, 2021
Impact of Mass Workplace COVID-19 Rapid Testing on Health and Healthcare Resource SavingsFrancesc López Seguí, Jose Maria Navarrete Duran, Albert Tuldrà, et al.
The Journal of Infectious Diseases|July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral TherapySilvia Bernal, Maria C Puertas, Sara Morón-López, et al.
The Lancet. HIV|August 5, 2024
Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohortJosep M Llibre, Boris Revollo, Jordi Aceiton, et al.
AIDS (London, England)|October 19, 2016
Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patientsNicolás Merchante, Sofía Ibarra, Boris Revollo, et al.
Scientific Reports|December 29, 2019
ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individualsMaria Pujantell, Roger Badia, Iván Galván-Femenía, et al.
Journal for Immunotherapy of Cancer|March 30, 2021
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)Maria Gonzalez-Cao, Teresa Puertolas, Mar Riveiro, et al.
Communications Biology|November 25, 2025
Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamstersNúria Pedreño-López, Ferran Tarrés-Freixas, Carla Usai, et al.
Pageof 3